Status:
UNKNOWN
Alpine vs. Xpedition: Evaluation of Stent Delivery System
Lead Sponsor:
University of Groningen
Collaborating Sponsors:
Abbott
Conditions:
Percutaneous Coronary Intervention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate and compare the performance of two stent delivery systems for percutaneous coronary intervention with everolimus-eluting stent.
Detailed Description
Rationale: The current gold standard for percutaneous coronary intervention (PCI) is the second generation drug-eluting stent (DES). The most commonly used DES is the everolimus-eluting stent (EES). N...
Eligibility Criteria
Inclusion
- All patients undergoing PCI with EES, aged 18 years or older
Exclusion
- Chronic total occlusion (CTO) PCI
- Inability to obtain (verbal) informed consent
Key Trial Info
Start Date :
October 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 5 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03451617
Start Date
October 5 2017
End Date
October 5 2020
Last Update
March 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9700 RB